Medically Reviewed By: Dr. Imran Khan, MD, IFMCP

Published: October 8, 2026

A Plant With a Long History in Cancer Care

Cancer treatment is demanding. Beyond surgery, chemotherapy, and radiation therapy, many patients look for ways to manage side effects and support their immune system throughout the process. That search often leads to integrative oncology and, increasingly, to mistletoe therapy.

For over a century, mistletoe therapy has been used in Europe as a complementary cancer support option, often with a focus on quality of life. At Internal Healing & Wellness MD, it is considered within a physician-guided functional medicine and integrative oncology approach used alongside conventional cancer care.

Physician discussing PMOS, hormonal health, fertility, and long-term health considerations with a female patient.

Disclaimer: This information is for educational purposes only and is not intended as medical advice. It does not replace, delay, or substitute standard oncology care, screening, diagnosis, or treatment recommended by your oncology team.

Mistletoe Therapy Explained

Mistletoe therapy uses extracts from European mistletoe, botanically known as Viscum album, a semiparasitic plant that grows on trees such as oak, pine, and apple. Its lectins, viscotoxins, and other compounds have been studied in laboratory and preclinical research for possible effects on immune activity and cancer-related cellular processes.

In cancer care, mistletoe is explored as a complementary therapy alongside conventional treatment. The National Cancer Institute notes that clinical evidence remains limited, so its use should be medically supervised and coordinated with the oncology plan.

How Mistletoe Therapy May Work in Cancer Care

Within laboratory and preclinical research, mistletoe compounds have demonstrated several biological activities:

  • Immune Cell Activity: May influence natural killer cells and other immune cells.
  • Programmed Cell Death: May trigger apoptosis, a process through which damaged or abnormal cells die.
  • Cell Movement: May affect processes involved in tumor-cell migration and invasion.
  • Blood Vessel Formation: May influence angiogenesis, the formation of blood vessels that can supply tumors.

These findings do not establish the same effects or clinical benefits in patients. The United States Food and Drug Administration (FDA) has not approved European mistletoe as a treatment for cancer or any other medical condition.

Mistletoe Therapy Delivery Options

Mistletoe therapy may be given through subcutaneous injection or IV infusion. Each route involves different dosing, administration, and monitoring requirements.

Subcutaneous Mistletoe Injections

Subcutaneous injections place the extract beneath the skin and are the most commonly described route for ongoing mistletoe therapy. Some patients may continue at home after the dose is established and their clinician approves and provides training.

Key considerations include:

  • Gradual Dosing: Treatment often begins at a low dose and is adjusted according to tolerance.
  • Flexible Setting: Approved patients may self-administer after clinical instruction.
  • Ongoing Schedule: Frequency depends on the product and individualized plan.

IV Mistletoe Therapy

IV mistletoe delivers the extract into the bloodstream through a supervised infusion. It has been studied in clinical settings and requires professional administration because reactions and dose changes must be monitored.

Patients can expect:

  • Clinician-Directed Dosing: The physician determines and adjusts the infusion dose.
  • In-Office Monitoring: Clinical staff supervise treatment and watch for reactions.
  • Scheduled Infusions: Timing reflects the patient’s condition and broader care plan.

Subcutaneous mistletoe offers more flexibility, while IV therapy requires supervised clinical visits. The choice depends on the patient’s diagnosis, current treatment, health history, and ability to self-administer.

What Research Says About Mistletoe Therapy

Research has primarily examined whether mistletoe therapy may help with symptoms and quality of life during cancer treatment. Findings are encouraging in some areas, but study quality varies, so the results do not support firm conclusions about treating or controlling cancer.

Potential Quality-of-Life Benefits

A systematic review and meta-analysis associated mistletoe therapy with better overall quality of life during cancer care, with some studies reporting benefits involving:

  • Physical Comfort: Less pain or nausea in some studies.
  • Daily Function: Better ability to manage routine activities.
  • Emotional Well-Being: Improvements in some patient-reported measures.

Clinical studies varied in design and quality, so these findings suggest potential benefits rather than a predictable response for every patient.

Reduced Cancer-Related Fatigue

Fatigue can make movement, concentration, and everyday responsibilities harder during cancer treatment. A longitudinal real-world study of patients with nonmetastatic breast cancer associated with add-on mistletoe therapy with improvements in fatigue and physical functioning, although the study design cannot establish cause and effect.

Preliminary Disease Observations

A Johns Hopkins Phase I trial found manageable toxicities with IV mistletoe in 21 patients with advanced, treatment-resistant cancers. Reported quality-of-life improvements and stable disease in five participants suggest that IV mistletoe merits further clinical study, but do not prove an anticancer benefit.

Overall, mistletoe research is more supportive of possible quality-of-life benefits than cancer control. Larger, well-designed clinical trials are still needed to clarify its effectiveness and appropriate use.

Mistletoe in Integrative Oncology

Within integrative oncology, mistletoe therapy may be considered for defined goals such as fatigue or quality of life. Suitability depends on the diagnosis, current treatment, medical history, laboratory findings, and potential risks.

If RGCC testing is already part of care, some panels may provide supplemental information about circulating tumor cells and related markers. However, RGCC results cannot determine whether mistletoe therapy is appropriate.

Clinical review may consider:

  • Treatment Stage: Active treatment, recovery, or survivorship.
  • Current Medications: Possible interactions or timing concerns with oncology treatment.
  • Blood Counts and Immune Factors: Infection concerns and immune-modifying treatments.
  • Quality-of-Life Goals: Fatigue, sleep, nausea, or daily function.

These factors help define a monitored, supportive role for mistletoe within the cancer treatment plan.

What to Expect From Mistletoe Therapy

Once mistletoe therapy is selected, the clinician establishes the administration plan and explains how the patient’s response will be followed. Expectations may include:

  • Dose Introduction: Treatment may begin at a lower dose and be adjusted according to tolerance.
  • Administration Guidance: Instructions reflect the prescribed product and delivery method.
  • Ongoing Monitoring: Reactions, symptoms, and changes in cancer treatment are reviewed over time.
  • Plan Adjustments: The dose or schedule may be changed or discontinued when clinically appropriate.

Possible Side Effects

Side effects can vary by product, dose, and delivery method. The National Cancer Institute identifies reactions such as:

  • Injection-Site Reactions: Soreness, redness, swelling, or inflammation.
  • Flu-Like Symptoms: Fever, chills, fatigue, or headache.
  • Other Reactions: Mild gastrointestinal symptoms, nausea, or allergic reactions.

Serious allergic reactions have been reported, but appear uncommon. Patients should promptly report new or worsening symptoms to their clinical team.

Take a Guided Approach to Mistletoe Therapy

Mistletoe therapy is not appropriate for every cancer patient and should not be pursued without clinical guidance. When medically appropriate, it may be explored to address symptom or quality-of-life goals within the oncology plan already in place.

If you want to understand whether mistletoe therapy may fit your cancer care, Internal Healing & Wellness MD can help you review the available evidence, potential risks, and treatment compatibility.

Schedule a mistletoe therapy consultation to explore whether it fits your cancer support plan.

Frequently Asked Questions

Yes. Cancer research has focused on European mistletoe, or Viscum album. American mistletoe is a different plant and should not be substituted for medically prepared European mistletoe extracts.

No. Most cancer research has evaluated prepared mistletoe extracts administered by healthcare professionals, while little research has examined oral use. Raw mistletoe leaves and berries can cause serious harmful effects when consumed.

There is no established timeline or guaranteed response. Changes in fatigue, nausea, sleep, or daily function should be tracked, with side effects or a lack of benefit prompting clinical review.

Yes. Adding a complementary therapy during cancer treatment can raise reasonable questions about safety and compatibility. A consultation provides an opportunity to discuss those concerns before deciding whether to proceed.

Coverage varies by insurance plan, product, and delivery method. Patients should ask the clinic about expected costs and contact their insurer before beginning therapy.

References: